RBC Capital has initiated coverage on Becton Dickinson and Co (BDX) with a Sector Perform rating as of September 24, 2025. This marks the firm's first assessment of the company, reflecting its analysis of Becton Dickinson's business dynamics and growth potential.
Becton Dickinson operates in the health care sector, focusing on the development, manufacture, and sale of medical supplies, devices, and diagnostic products. As of November 20, 2025, the company has a market capitalization of $54.6 billion, a P/E ratio of 32.53, and an EPS of 5.83. The firm currently does not offer a dividend yield.
Looking ahead, Becton Dickinson is set to report its next earnings on August 5, 2026, with expected EPS of $4.00 and revenue of $5.8 billion. The recent earnings performance shows stability, with Q4 2025 EPS reported at $3.96, meeting estimates, and previous quarters demonstrating positive surprises.
Analyst consensus indicates a Buy rating, with 4 Strong Buy, 4 Buy, and 11 Hold ratings among 19 total analysts. The announcement highlights the importance of considering multiple factors when making investment decisions, including company fundamentals and industry trends.
As analyst ratings can evolve with new information, they should be one of several inputs in investment considerations.